öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÍ¯¹â¶«
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º218

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º901µÚËÄÁÙ´²Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÖÐÎ÷Ò½½áºÏÖÎÁÆ·ÀÖÎÂýÐԸβ¡
Ñо¿ÁìÓò£º ÖÐÎ÷Ò½½áºÏÖÎÁÆ·ÀÖÎÂýÐԸβ¡ [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÊö
1963Äê1Ô³öÉú£¬°²»ÕºÏ·ÊÈË£¬ºº×壬Öй²²úµ³Ô±£¬¿ÆÊÒÖ÷ÈΣ¬²©Ê¿£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦¡£
Ö÷ÒªÈÙÓþ
2005¡¢2009Äê»ñµÃÖлªÖÐҽҩѧ»á¿Æ¼¼Êõ½±ÈýµÈ½±,
2009¡¢2010Äê»ñÉîÛÚÊпƼ¼´´ÐÂÓë½ø²½½±£¬
2011Äê»ñ¹ã¶«Ê¡¿Æ¼¼½ø²½ÈýµÈ½±£¬
2015Äê»ñÖлªÖÐҽҩѧ»á¿Æ¼¼Êõ½ø²½¶þµÈ½±¡£

¿ÆÑй¤×÷ :
ѧÊõ¼æÖ°
¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðίԱ»áÆÀί
ÖйúÃñ×åҽѧ»á¸Î²¡·Ö»á¸±»á³¤
¹ã¶«Ê¡ÖÐҽҩѧ»á¸Î²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áÖ÷ÈÎίԱ
¹ã¶«Ê¡Ò©Ñ§»áÖÐÒ©öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ί
ÉîÛÚÊÐÖÐҽҩѧ»á¸Îµ¨²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áÖ÷ÈÎίԱ
¹ã¶«Ê¡ÖÐҽѧ»áÀíÊ¡£
ÖлªÒ½Ôº¹ÜÀíѧ»áÓëÉîÛÚÊÐÎÀÉú¾ÖÖ÷°ìµÄ¹ú¼Ò¼¶ÆÚ¿¯¡¶º±ÉÙ¼²²¡ÔÓÖ¾¡·±àί¡£
SCI¡¶CHINESEJOURNALOFINTEGRATIVEMEDICINE¡·Éó¸åר¼Ò
¿ÆÑÐÏîÄ¿
¹ú¼Ò¡°Ê®ÈýÎ塱ÖØ´óרÏÖÐÒ½²¹Éö·¨¶ÔÂýÐÔHBVЯ´øÕßHbsAgתÒõ·½°¸µÄÑо¿£¬×鳤£¬2017.1-2020.12,1500Íò¡£
¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬¸´·½Ò¶ÏÂÖé¶ÔURG11½éµ¼HBVÏà¹ØHCCµÄ¦Â-catenin/Wnt×÷Ó㬸ºÔðÈË¡£2018.1-2021.12,54Íò
¹ã¶«Ê¡ÓÅÊƲ¡ÖÖÏîÄ¿£¬ÔÁ²ÆÉ磨2014£©539£¬Èí¸Î¿ÅÁ£ÖÎÁÆÒҸθÎÓ²»¯£¨»ý¾Û£©Ëæ»ú¶ÔÕÕÊÔÑ飬300Íò£¬2015.1-2018.1£¬µÚ¶þ¸ºÔðÈË
2¡¢¹ú¼ÒÖØ´ó¿Æ¼¼×¨Ï2008ZX1005-008£¬ÂýÐÔÒҸβ¡¶¾Ð¯´øÕßÖÐÒ½Ò©ÓÅ»¯ÖÎÁÆ·½°¸Ñо¿£¬2012-2015£¬ÒѽáÌ⣬¸±×鳤
3¡¢¹ú¼ÒÈËʲ¿Áôѧ¹é¹úÈËÔ±×ÊÖúÏîÄ¿£¬£¬)Ò¶ÏÂÖé¶Ô¸Îϸ°û°©ÐźŴ«µ¼µÄÓ°Ï죬2010-2013£¬ÒѽáÌ⣬Ö÷³Ö
4¡¢ÉîÛÚÊпƼ¼¼Æ»®ÏîÄ¿£¬**£¬¿¹Ñ×±£¸Î¶ÔÂýÐÔÒÒÐ͸ÎÑ×½øÕ¹¸Î°©Ó°ÏìµÄ³¤ÆÚ¶ÓÁÐÑо¿£¬2012-2014£¬Íò£¬ÒѽáÌ⣬Ö÷³Ö
5¡¢¹ã¶«Ê¡Ò©Ñ§»á¸ÎÑ׸ÎÒ©Ñо¿»ù½ð£¬2012G21£¬¶÷Ì濨ΤÖÎÁƺËÜպ˾­Öλ¼Õß³¤ÆÚ¶ÓÁÐÑо¿£¬2012-2014£¬ÒѽáÌ⣬Ö÷³Ö
6¡¢¹ú¼ÒÖØ´ó¿Æ¼¼×¨Ï2008ZX1005-008£¬ÂýÐÔÒҸβ¡¶¾Ð¯´øÕßµÄÖ¤ºò¹æÂɼ°ÖÐÒ½Ò©ÖÎÁÆ·½°¸Ñо¿£¬2008-2010£¬ÒѽáÌ⣬¸±×鳤
7¡¢ÉîÛÚÊпƼ¼¼Æ»®ÏîÄ¿£¬¿¹Ñ×±£¸Î¶ÔÂýÐÔÒÒÐ͸ÎÑ×»¼ÕßÁÙ´²½á¾ÖµÄÓ°Ï죬2009-2011£¬ÒѽáÌ⣬Ö÷³Ö
8¡¢¹ú¼ÒÈËʲ¿Áôѧ¹é¹úÈËÔ±ÔñÓÅ×ÊÖúÏîÄ¿£¬2006LHR11£¬¸´·½Ò¶ÏÂÖé·ÀÖÎÔçÆڸΰ©±äµÄÁÙ´²Ñо¿£¬2007-2010£¬ÒѽáÌ⣬Ö÷³Ö
9¡¢¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö£¬06-07JB05£¬¸Ï»Æ²Ý½þ¸à¶Ô´óÊó¸ÎÐÇ״ϸ°ûÖÐË¿ÁÑÔ­¼¤»îµ°°×¼¤Ã¸Â·¼°Smadsµ°°×ÐźÅתµ¼µÄÓ°Ï죬2007-2010£¬ÒѽáÌ⣬Ö÷³Ö
10¡¢ÉîÛÚÊпƼ¼ÏîÄ¿£¬**£¬Ð¸ΰ©Ç°¿¹Ìå¼ì²â¸ßΣ¶ÔÏó¼°Ò¶ÏÂÖ鸴·½·ÀÖÎÑо¿£¬2004-2006£¬ÒѽáÌ⣬Ö÷³Ö
11¡¢¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬C**£¬¸´·½Ò¶ÏÂÖé¶ÔHBxAgÖ¸ΰ©µÄ»úÀíÑо¿£¬2004-2005£¬ÒѽáÌ⣬Ö÷³Ö
12¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬**£¬¸´·½Ò¶ÏÂÖé¶ÔHBxAg¼°Æ伤»îURG4ºÍDRG1Òì³£±í´ïµÄÓ°Ï죬2004-2006£¬ÒѽáÌ⣬µÚ2Íê³ÉÈË
13¡¢¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö£¬02-03LP40£¬Æê·óÅäºÏ½á³¦±£Áô¹à³¦ÖÎÁÆÄÑÖÎÐÔ¸¹Ë®ÓÕ·¢µªÖÊѪ֢µÄз½·¨ÁÙ´²Ñо¿£¬2003-2005£¬µÚ2Íê³ÉÈË
Ö÷ÒªÂÛÎÄ
Ò».2016Äê¶È·¢±íÂÛÎÄ
1.Yu-fengXing,ZhenZhang,Wen-JunFu,Da-qiaoZhou,Ailsa,Chui-yingYuen,Daniel,Kam-wahMok,Chi-onChan,Guang-dongTong£¨Í¨Ñ¶×÷Õߣ©,ShuganXiaozhiDecoctionAttenuatesNon-alcoholicSteatohepatitis(NASH)byenhancingPPAR¦ÁandL-FABPexpressionsinHigh-fat-fedRats,Evidence-BasedComplementaryandAlternativeMedicine,2016ArticleID**
2.GuangdongTong,EffectofswitchingtooraddingonLtdonrenalfunctioninCHBwithsuboptimalresponsetoADVHepatologyInternational2016,10(Suppl1):S1¨CS506

¶þ.2015Äê¶È·¢±íÂÛÎÄ
1GuangdongTongLONG-TERMFOLLOW-UPOUTCOMEOFNON-ANTIVIRALTHERAPYINPATIENTSWITHCHRONICHEPATITISBHepatolInt(2015)9(Suppl1):S1¨CS391

Èý.2014Äê¶È·¢±íÂÛÎÄ
1.G£®D£®TongConstructionofaretroviralvectorcarryingvascularendothelialgrowthfactorreceptor3HepatologyInternational2014,HepatolInt(2015)9(Suppl1):S1¨CS311
2.YufengXing£¬GuangdongTong,JinsongHe,DaqiaoZhouEfficacyoftheexternalapplicationofshehuangpasteonumbilicusandchineseherbalcolondialysiscombinedwesternmedicineinrefractorycirrhoticascites£ºresultsfromamulticenter£¬randomized£¬controlledstudyHepatologyInternational2014,HepatolInt(2015)9(Suppl1):S1¨CS216

ËÄ£®2013Äê¶È·¢±íÂÛÎÄ
(1)ͯ¹â¶«EfficacyofEarlyTreatmenton52PatientswithPreneoplasticHepatitisBVirus-AssociatedHepatocellularCarcinomabyCompoundPhyllanthusUrinariaL.CHINESEJOURNALOFINTEGRATIVEMEDICINE2012onlineinpress15AprilJournalofAsianNaturalProductsResearchSCIÊÕ¼
(2)ChunWua,Chun-ShanWeiͯ¹â¶«(ͨѶ×÷Õß)TwonewacetylatedflavonoidglycosidesfromPhyllanthusurinariaPublishedonline:16May2013SICÊÕ¼
(3)ͯ¹â¶«Theantiviraleffectsofentecavirinnucleos(t)ideanalogue-experiencedchronic
hepatitisBpatientsHepatologyInternational2013.5:-558-559SCIÊÕ¼
£¨4£©Í¯¹â¶«EfficacyofswitchingtooraddingontelbivudineinpatientswithsuboptimalresponsetoadefovirdipivoxilHepatologyInternational2013.5:-558-559SCIÊÕ¼
£¨5£©ZHOUDa-qiao,HEJing-song,ͯ¹â¶«AClinicalTrailontheEfficacyandSafetyofAChineseHerbalFormula(Phyllanthuscompound.)fortheTreatmentofChronicHepatitisBVirusCarriers:RandomlyControlledandDouble-blind2013.5:-558-559SCIÊÕ¼
£¨6£©JinsongHeDaqiaoZhouGuangdongTong"EfficacyandSafetyofaChineseHerbalFormula(InvigoratingKidneyandStrengtheningSpleen)inChronicHepatitisBVirusCarrier:ResultsfromaMulticenter,Randomized,Double-Blind,andPlacebo-ControlledTrial,"Evidence-BasedComplementaryandAlternativeMedicinevol.2013,ArticleID961926,12pages,2013.doi:10.1155/2013/961926.

Î壮2012Äê¶È·¢±íÂÛÎÄ
(1)ÐÏÓî·æ£¬Í¯¹â¶«£¨Í¨Ñ¶×÷Õߣ©,ͯ¹â¶«½ÌÊÚÖÎÁƷǾƾ«ÐÔÖ¬·¾¸Î¾­Ñé×ܽá.ÁÉÄþÖÐÒ½Ò©´óѧѧ±¨201214£¨8£©178-179.
(2)κ´ºÉ½£¬Í¯¹â¶«£¨Í¨Ñ¶×÷Õߣ©,ÂýÐÔÒÒÐ͸ÎÑ×»¤¸ÎÖÎÁÆ»¼Õ߸ÎÓ²»¯Î£ÏÕÒòËØ·ÖÎö?.ʵÓÃҽѧÔÓÖ¾.2012(2)259-261.
(3)κ´ºÉ½£¬Í¯¹â¶«£¨Í¨Ñ¶×÷Õߣ©,¸Éϸ°ûÒÆÖ²ÖÎÁƸβ¡µÄÑо¿ÏÖ×´¼°Ó°ÏìÒòËØ[J].ҽѧ×ÛÊö,2012(19):3184-3186.
(4)ͯ¹â¶«EfficacyofUrsodeoxycholicAcidCombinedwithTongdanDecoctiononImmunologicalIndicesandHistopathologicalchangesinPrimaryBiliaryCirrhosisCHINESEJOURNALOFINTEGRATIVEMEDICINE**(1)16-22SCIÊÕ¼

Áù£®2012Ç°µÚ1×÷Õß·¢±íµÄÂÛÎÄ
(7)ͯ¹â¶«EarlytreatmentofPreneoplasticHepatitisBVirus-AssociatedHepatocellularCarcinomawithCompoundPhyllanthusUrinariaL(PPUL).HepatologyInternational2011.5:-558-559SCIÊÕ¼
(8)ͯ¹â¶«ÂýÐÔÒÒÐ͸ÎÑ×»¼Õßµ¥Óÿ¹Ñ×±£¸ÎÒ©ÎïÖÎÁƵij¤ÆÚËæ·Ã½á¹ûÖлª¸ÎÔಡÔÓÖ¾,**(9)701-703MedlineÊÕ¼
(9)ͯ¹â¶«PreneoplasticMarkersofHepatitisBVirus-AssociatedHepatocellularCarcinomaandaSignificanceofClinic.HepatologyInternational2008.2(1)SCIÊÕ¼
(10)ͯ¹â¶«¡¢ÕÅÏ£¡¢ÖÜ´óÇÅÒÒÐ͸ÎÑ×Ïà¹Ø¸Î°©µÄ°©Ç°²¡±äÔçÆÚ¸ÉÔ¤µÄÁÙ´²Ñо¿Öлª¸ÎÔಡÔÓÖ¾,2008(10)MedlineÊÕ¼
(11)ͯ¹â¶«¡¢ÖÜ´óÇÅ¡¢ºØ¾¢ËÉ.ÒÒÐ͸ÎÑ×Ïà¹Ø¸Î°©µÄ°©Ç°²¡±ä±êÖ¾Îï¼°ÆäÁÙ´²ÒâÒå.Öлª¸ÎÔಡÔÓÖ¾,200715£¨11£©MedlineÊÕ¼
(12)ͯ¹â¶«¡¢ÖÜ´óÇÅ¡¢ºØ¾¢ËÉ.÷ê»Æ¸àÆê·óÅäºÏ½á³¦Í¸ÎöÖÎÁÆÄÑÖÎÐÔ¸ÎÓ²»¯¸¹Ë®²¢·¢µªÖÊѪ֢µÄÁÙ´²Ñо¿ÖйúÖÐÎ÷Ò½½áºÏÔÓÖ¾,200828(09)IM/MEDLINEÊÕ¼
(13)Ìƺ£ºè,ͯ¹â¶«(ͨѶ×÷Õß).ÐÜÈ¥Ñõµ¨ËáÁªºÏͨµ¨ÌÀÖÎÁÆÔ­·¢ÐÔµ¨Ö­ÐÔ¸ÎÓ²»¯ÁÙ´²Ñо¿ÊÀ½ç»ªÈËÏû»¯ÔÓÖ¾200816£¨12£©CAÊÕ¼
(14)ÕÅÏ£,ͯ¹â¶«(ͨѶ×÷Õß)ÒÒÐ͸ÎÑײ¡¶¾Xµ°°×·´Ê½¼¤»îËùÖ¼¤»îµ°°×Òì³£±í´ïÓë¸Îϸ°û°©µÄÑо¿ÏÖ״賦²¡Ñ§Óë¸ÎÔಡѧÔÓÖ¾ºËÐÄÆÚ¿¯200817(7)
(15)¡¢ÐÏÓî·å¡¢ÕÅÏ£,ͯ¹â¶«(ͨѶ×÷Õß)µÈ.ÒÒ¸ÎIIIºÅÄÚÍâºÏÓÃÖÎÁÆÂýÐÔÒÒÐ͸ÎÑ׺ó¸ÎÏËά»¯Ô¶ÆÚÁÆЧ¡£ÊÀ½ç»ªÈËÏû»¯ÔÓÖ¾£¬2007£¬15£¨4£©,CAÊÕ¼
(16)TongGuangdong,ZhouDaqiao,HeJinsong,etal.ClinicalResearchonNavelApplicationofShehuangPasteCombinedwithChineseHerbalColonDialysisinTreatmentofRefractoryCirrhoticAscitesComplicatedwithAzotemiaWorldJournalofGasrtoenterology.2006,12(48)£º7798-7784SCIÊÕ¼
£¨17£©TongGuangdong,ZhouDaqiao,HeJinsong,etal,AntiviraleffectofChinesemedicineJiaweishinisaninhepatitisBvirustransgenicmiceWorldJGastroenterol2006April1412(14)2280-2283SCIÊÕ¼
(18)TongGuangdong,ZhouDaqiao,HeJinsong,etal,¡°effectsofnavel-stuckshehuangPasteonHemodynamics,Endotoxins,NitricOxideandEndothelininPafractorycirrhoticAscites¡±
CHINESEJOURNALOFINTEGRATIVEMEDICINE200612(4)255£­261SCIÊÕ¼
(19)ͯ¹â¶«ÅíʤȨ.¡°´Ó¡®ÉöÐé·üÆø¡¯ÂÛÂýÐÔÒÒÐ͸ÎÑ×µÄÖÎÁÆÖÐÒ½ÔÓÖ¾2004£¬45£¨10£©£º726£­728
(20)ͯ¹â¶«£¬ÖÜ´óÇÅ£¬Áõ»ÝÁᣬµÈ.¼ÓζËÄÄæÉ¢ÒÖÖÆHBVת»ùÒòСÊóHBVʵÑéÑо¿.ÖÐÎ÷Ò½½áºÏ¸Î²¡ÔÓÖ¾£¬2004Äê02ÆÚ
(21)ͯ¹â¶«²¡¶¾ÐÔÒÒÐ͸ÎÑ×ÖÂKwashiorkorÕ÷º±ÉÙ¼²²¡ÔÓÖ¾2003£º10£¨2£©
(22)ͯ¹â¶«£¬ÖÜ´óÇÅ÷ê»Æ¸àÆê·ó¶ÔÄÑÖÎÐÔ¸ÎÓ²»¯¸¹Ë®»¼ÕßѪÁ÷¶¯Á¦Ñ§ÓëNO±ä»¯µÄÓ°ÏìÖйúÖÐÒ½Ò©¿Æ¼¼200310(9)
(23)ͯ¹â¶«£¬ÖÜ´óÇÅ÷ê»Æ¸àÆê·óÖÎÁƸÎÓ²»¯ÄÑÖÎÐÔ¸¹Ë®ÁÙ´²Ñо¿ÖйúÖÐÎ÷Ò½½áºÏÏû»¯ÔÓÖ¾200311(5)
(24)ͯ¹â¶«£¬ÖÜ´óÇÅÒҸ΢óºÅºÏ½üºìÍâÐÅÏ¢·øÕÕÖÎÁÆÒҸθÎÏËά»¯µÄÁÙ´²Ñо¿°²»ÕÖÐҽѧԺѧ±¨200322(5)
(25)ͯ¹â¶«£¬ÖÜ´óÇÅÇå͸·¨¶Ô33ÀýÂýÐÔÒÒÐ͸ÎÑ×»¼ÕßTh1/Th2״̬µÄÓ°ÏìÖйúҽҩѧ±¨2002£º17£¨12£©
(26)ͯ¹â¶«£¬ÖÜ´óÇŲ¹ÉöÇå͸·½ÖÎÁÆÂýÐÔÒÒÐ͸ÎÑ×¼°Æä¶ÔHBVת»ùÒòСÊóMHC¿¹Ô­ÏµÍ³µÄÓ°ÏìÐÂÓ¢¸ñÀ¼ÖÐÒ½ÔÓÖ¾2002£¨1£©ÃÀ¹ú
(27)ͯ¹â¶«£¬ÅíʤȨ²¹ÉöÇå͸·¨ÖÎÁÆÂýÐÔÒÒÐ͸ÎÑ×62Àý°²»ÕÖÐҽѧԺѧ±¨2001£º20£¨4£©
(28)ͯ¹â¶«£¬ÅíʤȨ²¹ÉöÇ嶾·¨ÖÎÁÆÂýÐÔÒÒÐ͸ÎÑ×¾­Ñé°²»ÕÖÐҽѧԺѧ±¨2001£º20£¨1£©
(29)ͯ¹â¶«Î²¹ÅàÔª·½¶ÔÆ¢Ðé´óÊ󵨼îÄÜÉñ¾­ÖÕÄ©³¬Î¢½á¹¹±ä»¯µÄÓ°ÏìÖйúÖÐÎ÷Ò½½áºÏÏû»¯ÔÓÖ¾2000£º8£¨2£©
(30)ͯ¹â¶«Î²¹ÅàÔª·½¶ÔÆ¢ÉöÑôÐéÄ£ÐÍСÊóºìϸ°ûÃâÒß¹¦ÄܵÄÓ°ÏìÖйúÖÐÒ½Ò©¿Æ¼¼2000£º7£¨3£©
(31)ͯ¹â¶«Î²¹ÅàÔª·½¶ÔÆ¢ÐéСÊóÃâÒß¹¦ÄÜÓ°ÏìµÄʵÑéÑо¿Öйúҽҩѧ±¨2000£º15£¨6£©
(32)ͯ¹â¶«£¬ÅíʤȨ²¹Çå͸·½ÖÎÁÆÂýÐÔÒÒÐ͸ÎÑ×¼°Æä¶ÔHBVת»ùÒòСÊóMHC¿¹Ô­ÏµÍ³µÄÓ°ÏìÐÂÓ¢¸ñÀ¼ÖÐÒ½ÔÓÖ¾2002£¨1£©

Æߣ®½ü5ÄêºÏ×÷·¢±íÖ÷ҪѧÊõÂÛÎÄ
(33)ÖÜ´óÇÅ,ºØ¾¢ËÉ,ͯ¹â¶«.³¶¸ù²Ë¶Ô¸ÎÐÇ״ϸ°û·ÖÃÚת»¯Éú³¤Òò×Ó-B1¼°IÐͽºÔ­µÄÓ°Ïì.Öлª´«È¾²¡ÔÓÖ¾.2008:26(12):711-715
(34)³ÂТÒø£¬Í¯¹â¶«.¡°AntivaleffectofChinesemedicinejiaweisinisaninhepatitsBvirustransgenicmice¡±WorldJGarstoenteral2006April1412(14):2280-2283
SCIÊÕ¼
(35)ÖÜ´óÇÅ£¬Í¯¹â¶«£¬ºØ¾¢Ëɸ´·½Ò¶ÏÂÖé¶ÔÈ˸ΰ©Ï¸°ûÒÆÖ²ÂãÊóHBxAg±í´ïµÄÓ°Ïì¼°¶ÔHCCµÄ·ÀÖÎÒâÒåÖйúÖÐÒ©ÔÓÖ¾£¬2006:19£¨10£©
(36)ÖÜ´óÇÅ£¬Í¯¹â¶«£¬ºØ¾¢ËÉ£¬µÈ.ÖÐÒ©¸´·½Ò¶ÏÂÖé·ÀÖθΰ©µÄ²¡»ú·ÖÎö.ÖÐÒ½ÔÓÖ¾£¬2005Äê12ÔÂS1
(37)ÙÜÊÀ·æ£¬»ÆÏÍÕÁ£¬Í¯¹â¶«.²»Í¬¼ÁÁ¿µ¤²Î×¢ÉäÒº¿¹¸ÎÏËά»¯ÁÙ´²Ñо¿.ÖйúÖÐÎ÷Ò½½áºÏÔÓÖ¾£¬2004Äê01ÆÚMedlineÊÕ¼
(38)ÅíÁ¢Éú,ºØ¾¢ËÉ,ͯ¹â¶«.Ò¶ÏÂÖéÌáÌáÈ¡ÎÒҸβ¡¶¾¼°ÒҸβ¡¶¾X»ùÒòµÄÑо¿.ÖÐÎ÷Ò½½áºÏÔÓÖ¾.200616(6):340-343
(39£©³ÂТÒø£¬Îº´ºÉ½£¬Í¯¹â¶«ÇíÓñ¸àÒÖÖƸÎϸ°û°©HBxAg±í´ï¼°Æä¶ÔÔ­·¢ÐÔ¸Îϸ°ûµÄ·ÀÖÎ×÷ÓÃ.ϸ°ûÓë·Ö×ÓÃâÒßѧÔÓÖ¾200723(1):56-58
(40)ºØ¾¢ËÉ,ͯ¹â¶«.Èí¸Î·½ºÏ÷ê»Æ¸à·óÆê¼°¸¹Ë®³¬ÂËŨËõ»ØÊäÖÎÁÆÍç¹ÌÐÔ¸ÎÓ²»¯¸¹Ë®µÄÁÙ´²Ñо¿.ÖÐÎ÷Ò½½áºÏ¸Î²¡ÔÓÖ¾.201121(3)
(41)ºØ¾¢ËÉ,ͯ¹â¶«³¶¸ù²Ë½þ¸à¶ÔTGF-¦Â1¸ÎÐÇ״ϸ°û°ûÄÚÐźÅתµ¼Í¨Â·µÄÓ°Ïì.¹ú¼ÊÏû»¯²¡ÔÓÖ¾200929(3)
(42)°½·É½¡£¬Í¯¹â¶«¾ÛÒÒ¶þ´¼¸ÉÈÅËئÁ-2a¡¢°¢µÂ¸£Î¤õ¥µ¥Óü°ÁªºÏÓ¦ÓÃÖÎÁÆHBeAgÑôÐÔÂýÐÔÒÒÐ͸ÎÑ×»¼ÕßµÄÁÆЧ¼°°²È«ÐԱȽÏÖлª´«È¾²¡ÔÓÖ¾.2010:28(4)
£¨43£©ÂÀº­Çåͯ¹â¶«ºË´Å¹²ÕñºÍÊý×Ö¼õӰѪ¹ÜÏÔÓ°ÁªºÏÓ¦ÓöԸÎÓ²»¯½á½Ú°©±äµÄÔçÆÚÕï¶Ï¼ÛÖµÖйú»ù²ãÒ½Ò©201017£¨20£©
£¨44£©Çñ÷ͯ¹â¶«¸Î¼ôÇв¨ËÙÔÚÂýÐÔÒÒÐ͸ÎÑײ¡¶¾Ð¯´øÕ߸ÎÏËά»¯·ÖÆÚÉϵÄÁÙ´²ÒâÒåÁÙ´²¸Îµ¨²¡ÔÓÖ¾201026£¨4£©

½ÌÓý±³¾° :
1979-1984°²»ÕÖÐҽѧԺÖÐҽϵ±¾¿Æ
1984-1987°²»ÕÖÐҽѧԺ¸½ÔºÄÚ¿ÆסԺҽʦ
1987-1990°²»ÕÖÐҽѧԺÑо¿Éú
1990-1998°²»ÕÖÐҽѧԺ¿ÆÑд¦¸±Ñо¿Ô±
1998-2001¹ãÖÝÖÐÒ½Ò©´óѧβ¡öλÔÓéÀֵǼÈë¿ÚÏÂÔز©Ê¿Éú
2001-2004ÉîÛÚÖÐÒ½Ôº¸Î²¡¿Æ¸±Ö÷ÈÎҽʦ£¬Ö÷ÈÎҽʦ
2004-2005ÃÀ¹úThomasJeffersonUniversity·ÃÎÊѧÕß
2005-ÖÁ½ñÉîÛÚÊÐÖÐÒ½ÔºÖ÷ÈÎҽʦ£¬½ÌÊÚ£¬²©µ¼